Pharmacoepigenomic impact of antihypertensive drugs on miRome and proteome and its potential impact on health and side effects

SUPPLEMENTARY FIGURES: Figure S1: Methodology flow chart Figure S2: MTT assay showing cell viability for different drug concentrations and time points SUPPLEMENTARY TABLES: Table S1: Significantly regulated miRNAs (P-values < 0.05) with the respective fold change Table S2: The validated target genes (3' UTR binding, binding score ≥ 0.95) derived from miRwalk database Table S3: Validated miRNA target genes associated with Hypertension Table S4: Validated miRNA target genes and the side effects associated in terms of HPO database Table S5: Significantly differentially regulated proteins